Article Details

Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term

Retrieved on: 2021-06-14 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term. View article details on hiswai:

Excerpt

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up